Publicou 6 edições por ano
ISSN Imprimir: 1040-8401
ISSN On-line: 2162-6472
Indexed in
Shigellosis: Innate Mechanisms of Inflammatory Destruction of the Intestinal Epithelium, Adaptive Immune Response, and Vaccine Development
RESUMO
Acute infectious colitis remains a major pediatric issue of worldwide impact because it still represents a significant public health burden among the larger group of diarrheal diseases with the highest mortality rate. It is also a relevant model of inflammatory bowel diseases (IBD), such as Crohn’s disease and ulcerative colitis. Among cases of acute colitis of infectious origin, shigellosis is certainly the one that has benefited the most from a significant research effort. Shigella, the causative agent, is a Gram-negative bacterium that has the capacity to invade, disrupt, and cause inflammatory destruction of the intestinal epithelial barrier. The molecular and cellular bases of this invasive phenotype essentially encompass crossing of the epithelial lining, apoptotic killing of macrophages, entry into epithelial cells, and escape into the cytoplasm, followed by cell-to-cell spread. Intracellular colonization is likely to protect the micro-organisms from killing by humoral and cellular effectors of the innate immune response. Concurrently, the capacity of Shigella to reprogram invaded epithelial cells to produce proinflammatory mediators plays a major role in the strong inflammatory profile of the disease. This profile is likely to impact on the nature and quality of the adaptive response, which is dominated by humoral protection at the mucosal level.
-
Payne Shelley M., Wyckoff Elizabeth E., Murphy Erin R., Oglesby Amanda G., Boulette Megan L., Davies Nicola M. L., Iron and Pathogenesis of Shigella: Iron Acquisition in the Intracellular Environment, BioMetals, 19, 2, 2006. Crossref
-
Parsot Claude, Shigellaspp. and enteroinvasiveEscherichia colipathogenicity factors, FEMS Microbiology Letters, 252, 1, 2005. Crossref
-
Navaneethan Udayakumar, Giannella Ralph A, Mechanisms of infectious diarrhea, Nature Clinical Practice Gastroenterology & Hepatology, 5, 11, 2008. Crossref
-
Pallen Mark J., Beatson Scott A., Bailey Christopher M., Bioinformatics, genomics and evolution of non-flagellar type-III secretion systems: a Darwinian perpective, FEMS Microbiology Reviews, 29, 2, 2005. Crossref
-
Schroeder Gunnar N., Hilbi Hubert, Cholesterol is required to trigger caspase-1 activation and macrophage apoptosis after phagosomal escape of Shigella, Cellular Microbiology, 9, 1, 2007. Crossref
-
Hummel Susanne, Apte Ron N, Qimron Udi, Vitacolonna Mario, Porgador Angel, Zöller Margot, Tumor Vaccination by Salmonella typhimurium After Transformation with a Eukaryotic Expression Vector in Mice, Journal of Immunotherapy, 28, 5, 2005. Crossref
-
Wolf Ronni, Grimaldi Elena, Donnarumma Giovanna, Greco Rita, Auricchio Lucia, Filippis Anna, Tufano Maria Antonietta, Quinine Sulfate Inhibits Invasion of Salmonella typhimurium and Shigella flexneri: A Preliminary Study, Journal of Travel Medicine, 12, 6, 2006. Crossref
-
Navaneethan Udayakumar, Giannella Ralph A, Infectious colitis, Current Opinion in Gastroenterology, 27, 1, 2011. Crossref
-
Nagy Gábor, Emo˝dy Levente, Pál Tibor, Strategies for the development of vaccines conferring broad-spectrum protection, International Journal of Medical Microbiology, 298, 5-6, 2008. Crossref
-
Clinical Guideline for the Diagnosis and Treatment of Gastrointestinal Infections, Infection and Chemotherapy, 42, 6, 2010. Crossref
-
Sherman Michael P., New Concepts of Microbial Translocation in the Neonatal Intestine: Mechanisms and Prevention, Clinics in Perinatology, 37, 3, 2010. Crossref
-
Taylor D. N., McKenzie R., Durbin A., Carpenter C., Atzinger C. B., Haake R., Bourgeois A. L., Rifaximin, a Nonabsorbed Oral Antibiotic, Prevents Shigellosis after Experimental Challenge, Clinical Infectious Diseases, 42, 9, 2006. Crossref
-
Venkatesan Malabi M, Ranallo Ryan T, Live-attenuatedShigellavaccines, Expert Review of Vaccines, 5, 5, 2006. Crossref
-
Berlutti Francesca, Schippa Serena, Morea Clara, Sarli Serena, Perfetto Brunella, Donnarumma Giovanna, Valenti Piera, Lactoferrin downregulates pro-inflammatory cytokines upexpressed in intestinal epithelial cells infected with invasive or noninvasive Escherichia coli strainsThis paper is one of a selection of papers published in this Special Issue, entitled 7th International Conference on Lactoferrin: Structure, Function, and Applications, and has undergone the Journal’s usual peer review process., Biochemistry and Cell Biology, 84, 3, 2006. Crossref
-
Chapel H., Puel A., von Bernuth H., Picard C., Casanova J.-L., Shigella sonnei Meningitis Due to Interleukin-1 Receptor--Associated Kinase--4 Deficiency: First Association with a Primary Immune Deficiency, Clinical Infectious Diseases, 40, 9, 2005. Crossref
-
Rawal Monica, Hoff Elsebeth, Aas-Pedersen Lena, Haugum Kjersti, Lindstedt Bjørn-Arne, Rapid multiple-locus variable-number tandem-repeats analysis of Shigella spp. using multicolour capillary electrophoresis, Journal of Microbiological Methods, 83, 3, 2010. Crossref
-
Giannella Ralph A., Infectious Enteritis and Proctocolitis and Bacterial Food Poisoning, in Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 2010. Crossref
-
Camacho Ana Isabel, Irache Juan Manuel, Gamazo Carlos, Recent progress towards development of aShigellavaccine, Expert Review of Vaccines, 12, 1, 2013. Crossref
-
Phalipon Armelle, Sansonetti Philippe J, Shigella’ s ways of manipulating the host intestinal innate and adaptive immune system: a tool box for survival? , Immunology & Cell Biology, 85, 2, 2007. Crossref
-
Burnaevskiy Nikolay, Fox Thomas G., Plymire Daniel A., Ertelt James M., Weigele Bethany A., Selyunin Andrey S., Way Sing Sing, Patrie Steven M., Alto Neal M., Proteolytic elimination of N-myristoyl modifications by the Shigella virulence factor IpaJ, Nature, 496, 7443, 2013. Crossref
-
Mitra Soma, Chakrabarti Manoj K., Koley Hemanta, Multi-serotype outer membrane vesicles of Shigellae confer passive protection to the neonatal mice against shigellosis, Vaccine, 31, 31, 2013. Crossref
-
Ross Allen G.P., Olds G. Richard, Cripps Allan W., Farrar Jeremy J., McManus Donald P., Enteropathogens and Chronic Illness in Returning Travelers, New England Journal of Medicine, 368, 19, 2013. Crossref
-
Marteyn Benoit, Gazi Anastasia, Sansonetti Philippe, Shigella, Gut Microbes, 3, 2, 2012. Crossref
-
Fisher Michael L., Sun Wei, Curtiss Roy, The route less taken: pulmonary models of enteric Gram-negative infection, Pathogens and Disease, 70, 2, 2014. Crossref
-
Leung J.M., Gallant C.V., Infections due to Escherichia and Shigella☆, in Reference Module in Biomedical Sciences, 2014. Crossref
-
Toapanta Franklin R., Simon Jakub K., Barry Eileen M., Pasetti Marcela F., Levine Myron M., Kotloff Karen L., Sztein Marcelo B., Gut-Homing Conventional Plasmablasts and CD27− Plasmablasts Elicited after a Short Time of Exposure to an Oral Live-Attenuated Shigella Vaccine Candidate in Humans, Frontiers in Immunology, 5, 2014. Crossref
-
Nag D., Koley H., Sinha R., Mukherjee P., Sarkar C., Withey J. H., Gachhui R., Immunization of Mice with a Live Transconjugant Shigella Hybrid Strain Induced Th1 and Th17 Cell-Mediated Immune Responses and Confirmed Passive Protection Against Heterologous Shigellae, Scandinavian Journal of Immunology, 83, 2, 2016. Crossref
-
Davis Courtney L., Wahid Rezwanul, Toapanta Franklin R., Simon Jakub K., Sztein Marcelo B., Levy Doron, Turner Stephen J., Applying Mathematical Tools to Accelerate Vaccine Development: Modeling Shigella Immune Dynamics, PLoS ONE, 8, 4, 2013. Crossref
-
Arena Ellen T., Tinevez Jean-Yves, Nigro Giulia, Sansonetti Philippe J., Marteyn Benoit S., The infectious hypoxia: occurrence and causes during Shigella infection, Microbes and Infection, 19, 3, 2017. Crossref
-
Barman Soumik, Saha Dhira Rani, Ramamurthy Thandavarayan, Koley Hemanta, Development of a new guinea-pig model of shigellosis, FEMS Immunology & Medical Microbiology, 62, 3, 2011. Crossref
-
Schröder-Braunstein Jutta, Gras Judith, Brors Benedikt, Schwarz Sonja, Szikszai Timea, Lasitschka Felix, Wabnitz Guido, Heidtmann Antje, Lee Young-Seon, Schiessling Serin, Leowardi Christine, Al-Saeedi Mohammed, Ulrich Alexis, Engelke Antonia, Winter Johannes, Samstag Yvonne, Giese Thomas, Meuer Stefan, Karhausen Jörn, Initiation of an Inflammatory Response in Resident Intestinal Lamina Propria Cells -Use of a Human Organ Culture Model, PLoS ONE, 9, 5, 2014. Crossref
-
Morinaga Yoshitomo, Yanagihara Katsunori, Nakamura Shigeki, Hasegawa Hiroo, Seki Masafumi, Izumikawa Koichi, Kakeya Hiroshi, Yamamoto Yoshihiro, Yamada Yasuaki, Kohno Shigeru, Kamihira Shimeru, Legionella pneumophila induces cathepsin B-dependent necrotic cell death with releasing high mobility group box1 in macrophages, Respiratory Research, 11, 1, 2010. Crossref
-
Blanco David A., Pall Harpreet, Inflammatory Enteritis, in Principles and Practice of Pediatric Infectious Diseases, 2018. Crossref
-
Sagaert Xavier, Dysentery, Bacillary, in Pathology of the Gastrointestinal Tract, 2017. Crossref
-
Qian Tian, Zhang Rong, Zhu Li, Shi Peng, Yang Jie, Yang Chang-yi, Chen Dong-mei, Shi Jing-yun, Zhou Xiao-guang, Qiu Yin-ping, Yang Yong, He Ling, He Shao-ru, Cao Yun-tao, Wei Qiu-fen, Kumar Manoj, Chen Chao, Necrotizing enterocolitis in low birth weight infants in China: Mortality risk factors expressed by birth weight categories, Pediatrics & Neonatology, 58, 6, 2017. Crossref
-
Davis Courtney L., Wahid Rezwanul, Toapanta Franklin R., Simon Jakub K., Sztein Marcelo B., Kaderali Lars, A clinically parameterized mathematical model of Shigella immunity to inform vaccine design, PLOS ONE, 13, 1, 2018. Crossref
-
Le-Barillec Karine, Magalhaes Joao Gamelas, Corcuff Erwan, Thuizat Audrey, Sansonetti Philippe J., Phalipon Armelle, Di Santo James P., Roles for T and NK Cells in the Innate Immune Response toShigella flexneri, The Journal of Immunology, 175, 3, 2005. Crossref
-
Suzuki Toshihiko, Yoshikawa Yuko, Ashida Hiroshi, Iwai Hiroki, Toyotome Takahito, Matsui Hidenori, Sasakawa Chihiro, High Vaccine Efficacy against Shigellosis of Recombinant NoninvasiveShigellaMutant That ExpressesYersiniaInvasin, The Journal of Immunology, 177, 7, 2006. Crossref
-
Phalipon Armelle, Costachel Corina, Grandjean Cyrille, Thuizat Audrey, Guerreiro Catherine, Tanguy Myriam, Nato Farida, Vulliez-Le Normand Brigitte, Bélot Frédéric, Wright Karen, Marcel-Peyre Véronique, Sansonetti Philippe J., Mulard Laurence A., Characterization of Functional Oligosaccharide Mimics of theShigella flexneriSerotype 2a O-Antigen: Implications for the Development of a Chemically Defined Glycoconjugate Vaccine, The Journal of Immunology, 176, 3, 2006. Crossref
-
Stein J., Kist M., Shigellenenteritis, in Infektiologie des Gastrointestinaltraktes, 2006. Crossref
-
Stephens Ina, Nataro James P., Inflammatory Enteritis, in Principles and Practice of Pediatric Infectious Disease, 2008. Crossref
-
Stephens Ina, Nataro James P., Inflammatory Enteritis, in Principles and Practice of Pediatric Infectious Diseases, 2012. Crossref
-
Yang Jieping, Guo Yuanqiang, Lee Rupo, Henning Susanne M, Wang Jing, Pan Yajing, Qing Tianyu, Hsu Mark, Nguyen Alex, Prabha Siddarth, Ojha Rashi, Small Gary W, Heber David, Li Zhaoping, Pomegranate Metabolites Impact Tryptophan Metabolism in Humans and Mice, Current Developments in Nutrition, 4, 11, 2020. Crossref
-
Toapanta Franklin R., Bernal Paula J., Kotloff Karen L., Levine Myron M., Sztein Marcelo B., T cell mediated immunity induced by the live-attenuated Shigella flexneri 2a vaccine candidate CVD 1208S in humans, Journal of Translational Medicine, 16, 1, 2018. Crossref
-
Zong Wei-Xing, Thompson Craig B., Necrotic death as a cell fate, Genes & Development, 20, 1, 2006. Crossref
-
Clément Marie-Jeanne, Fortuné Antoine, Phalipon Armelle, Marcel-Peyre Véronique, Simenel Catherine, Imberty Anne, Delepierre Muriel, Mulard Laurence A., Toward a Better Understanding of the Basis of the Molecular Mimicry of Polysaccharide Antigens by Peptides, Journal of Biological Chemistry, 281, 4, 2006. Crossref
-
Melton‐Celsa Angela R., Robinson C. M., Smith M. J., O'Brien A. D., Shiga Toxins (Stxs): Multifaceted Pathogenicity Determinants, in Virulence Mechanisms of Bacterial Pathogens, 2007. Crossref
-
Poole Nina M., Green Sabrina I., Rajan Anubama, Vela Luz E., Zeng Xi-Lei, Estes Mary K., Maresso Anthony W., Bäumler Andreas J., Role for FimH in Extraintestinal Pathogenic Escherichia coli Invasion and Translocation through the Intestinal Epithelium, Infection and Immunity, 85, 11, 2017. Crossref
-
Nag Dhrubajyoti, Sinha Ritam, Mitra Soma, Barman Soumik, Takeda Yoshifumi, Shinoda Sumio, Chakrabarti M.K., Koley Hemanta, Heat killed multi-serotype Shigella immunogens induced humoral immunity and protection against heterologous challenge in rabbit model, Immunobiology, 220, 11, 2015. Crossref
-
Orr Nadav, Katz David E., Atsmon Jacob, Radu Paull, Yavzori Miri, Halperin Tamar, Sela Tamar, Kayouf Raid, Klein Zivit, Ambar Ruhama, Cohen Dani, Wolf Marcia K., Venkatesan Malabi M., Hale Thomas L., Community-Based Safety, Immunogenicity, and Transmissibility Study of the Shigella sonnei WRSS1 Vaccine in Israeli Volunteers , Infection and Immunity, 73, 12, 2005. Crossref
-
Ma Xianzong, Lu Xiaojuan, Zhang Wenyu, Yang Lang, Wang Dezhi, Xu Junfeng, Jia Yan, Wang Xin, Xie Hui, Li Shu, Zhang Mingjie, He Yuqi, Jin Peng, Sheng Jianqiu, Gut microbiota in the early stage of Crohn’s disease has unique characteristics, Gut Pathogens, 14, 1, 2022. Crossref